Aurobindo Pharma Board Approves Merger of Subsidiaries

Aurobindo Pharma Ltd's Board of Directors has approved a proposal to merge two step-down wholly owned subsidiaries, Eugia Steriles Private Limited and Eugia SEZ Private Limited, with Eugia Pharma Specialities Limited, a wholly owned subsidiary. The merger aims to simplify the group structure, eliminate corporate overheads, reduce costs, and improve treasury management and synergy benefits. All three entities are involved in the manufacturing of injectable pharmaceutical products. The transaction is between wholly owned subsidiaries and does not involve any cash consideration or change in the listed entity's shareholding pattern. The combined turnover for FY26 of the three entities was approximately ₹32,196 million.